Latest News

The votes came in at 17 to 6 last week and the advisory panel to the FDA (Food and Drug Administration) has indicated to the regulators that weight loss drugs should go through clinical trials specifically gauging potential cardiovascular risk, even if there is no reason to suspect that a particular...

Rates of kidney cancer have reached an all-time high and according to the experts, this is directly related to the currently increasing obesity rates...

The American drug regulator, the Food and Drug Administration (FDA), stated in a report yesterday that it may consider mandatory cardiovascular risk studies before considering any weight loss medication for approval, even if there is no evidence to suggest that there is any cardiovascular risk assoc...

The European Medicines Agency (EMA) has accepted the submission by Arena Pharmaceuticals of their Marketing Authorisation Application for Lorcaserin...

It has long been known that viruses can weaken cancer cells but previous attempts to apply this knowledge to help cancer patients left them with only a short term recovery and in many cases, these cancer sufferers actually died as a result of the potency of the virus that was administered into their...